Conduit Pharmaceuticals I...

NASDAQ: CDT · Real-Time Price · USD
1.62
-0.05 (-2.99%)
At close: Aug 15, 2025, 3:59 PM
1.64
1.23%
After-hours: Aug 15, 2025, 04:04 PM EDT

Conduit Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
922.22M n/a n/a n/a
Cost of Revenue
457K n/a n/a n/a
Gross Profit
-457K n/a n/a n/a
Operating Income
-15.42M -5.56M -3.16M -3.17M
Interest Income
13K 15K 1.98M n/a
Pretax Income
-17.8M -535K -4.89M -4.38K
Net Income
-17.8M -535K -4.89M -3.66M
Selling & General & Admin
12.04M 5.47M 3.05M 2.89M
Research & Development
3.38M 90K 111K 283K
Other Expenses
-457K n/a n/a n/a
Operating Expenses
14.96M 5.56M 3.16M 3.17M
Interest Expense
1.51M 211K n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
15.42M 5.56M 3.16M 3.17M
Income Tax Expense
n/a n/a n/a 247.44K
Shares Outstanding (Basic)
2.03M 1.67M 3.62M 576.15
Shares Outstanding (Diluted)
2.06M 1.7M 3.62M 576.15
EPS (Basic)
-20.53 -3.6 -11.2 -1.01
EPS (Diluted)
-20.53 -3.6 -11.2 -1.01
EBITDA
-15.84M -324K -1.43M -4.38K
EBIT
-16.3M -324K -4.89M -4.38K
Depreciation & Amortization
457K 167.9K 1.73M n/a